Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain

Marc Miravitlles,1 Miguel Roman-Rodríguez,2,3 Xavier Ribera,4 John Ritz,5 José Luis Izquierdo6,7 On behalf of OPTI investigator’s group1Pneumology Department, Hospital Universitari Vall d´Hebron/Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades...

Full description

Bibliographic Details
Published in:	International Journal of COPD
Main Authors:	Miravitlles M, Roman-Rodríguez M, Ribera X, Ritz J, Izquierdo JL
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-01-01
Subjects:	chronic obstructive pulmonary disease primary care inhaled corticosteroids exacerbations.
Online Access:	https://www.dovepress.com/inhaled-corticosteroid-use-among-copd-patients-in-primary-care-in-spai-peer-reviewed-fulltext-article-COPD

Similar Items

Minimising inhaled corticosteroids for COPD
by: Benji Heran, et al.
Published: (2024-12-01)

Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD
by: Nan Ma, et al.
Published: (2021-02-01)

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
by: Marc Miravitlles, et al.
Published: (2017-11-01)

A Prediction Scoring Model for the Effect of Withdrawal or Addition of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease
by: Lee JH, et al.
Published: (2023-02-01)

Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History
by: Andrea S. Melani, et al.
Published: (2024-02-01)

The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
by: Wang CY, et al.
Published: (2016-11-01)

Lack of Association between Inhaled Corticosteroid Use Based on the Exhaled Nitric Oxide and Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Bo-Guen Kim, et al.
Published: (2024-07-01)

Exacerbations in COPD patients treated with Inhaled Corticosteroids/Long-acting β2 agonists combinations, switching to another combination drugs or inhaler device: A “real – world” study
by: Diego Sangiorgi, et al.
Published: (2017-01-01)

Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
by: Mario Cazzola, et al.
Published: (2023-07-01)

Radiographic Phenotypes Affect the Risk of Inhaled Corticosteroid-Associated Pneumonia in Patients with COPD
by: Lee HJ, et al.
Published: (2022-09-01)

A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management
by: Micheletto C, et al.
Published: (2019-09-01)

Prevalence and Clinical Outcomes of Eosinophilic COPD in a Saudi Population: A Retrospective Study
by: Fareed Alshehri, et al.
Published: (2025-01-01)

Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers
by: Wittbrodt ET, et al.
Published: (2018-12-01)

Association between inhaled corticosteroid use and risk of hyperglycemia in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
by: Fathur Nur Kholis, et al.
Published: (2023-01-01)

High versus Medium Dose of Inhaled Corticosteroid in Chronic Obstructive Lung Disease: A Systematic Review and Meta-Analysis
by: Archontakis Barakakis P, et al.
Published: (2023-04-01)

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes
by: Bosnic-Anticevich S, et al.
Published: (2016-12-01)

Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
by: Elvis M. Irusen, et al.
Published: (2020-12-01)

Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study
by: Hashimoto S, et al.
Published: (2023-01-01)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
by: Yoon JK, et al.
Published: (2020-08-01)

IgE Guided Use of ICS in Patients with Stable COPD: A Real-World Observational Study
by: Ziwei Zhou, et al.
Published: (2025-10-01)

Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
by: Wang Chun Kwok, et al.
Published: (2023-06-01)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
by: Song JH, et al.
Published: (2017-08-01)

Elevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy
by: Wang Hao-Chien, et al.
Published: (2011-09-01)

Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
by: Erminia Ridolo, et al.
Published: (2018-05-01)

Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study
by: Janwillem Kocks, et al.
Published: (2023-08-01)

Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids
by: Yong Suk Jo, M.D., et al.
Published: (2020-01-01)

Inhaled Corticosteroids and the Lung Microbiome in COPD
by: Holly R. Keir, et al.
Published: (2021-09-01)

An assessment of asthma exacerbations in pediatric patients using a long-acting B2-agonist plus inhaled corticosteroid versus an inhaled corticosteroid alone
by: Yousif S. Alakeel, et al.
Published: (2022-03-01)

Inhaled Corticosteroids May Not Affect the Clinical Outcomes of Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
by: Min-Seok Chang, et al.
Published: (2024-07-01)

Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children
by: Vasbinder EC, et al.
Published: (2016-04-01)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
by: Koehorst-ter Huurne K, et al.
Published: (2016-07-01)

COPD from an everyday primary care point of view
by: Antonio L Aguilar-Shea, et al.
Published: (2019-01-01)

Evaluating inhaled corticosteroids' impact on osteoporosis and fracture risk in COPD patients: a real-world evidence-based systematic review and meta-analysis
by: Hsiao-Feng Huang, et al.
Published: (2025-06-01)

Inhaled corticosteroid treatment and pneumonia in patients with chronic obstructive pulmonary disease – nationwide development from 1998 to 2018
by: Allan Klitgaard, et al.
Published: (2024-12-01)

Single-versus multiple-inhaler triple therapy in patients with COPD in Spain: a retrospective cohort study comparing adherence, persistence, risk of exacerbations and economic outcomes
by: M. Asunción González-González, et al.
Published: (2025-09-01)

Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain
by: Neches García V, et al.
Published: (2022-09-01)

Efficacy of ICS versus Non-ICS Combination Therapy in COPD: A Meta-Analysis of Randomised Controlled Trials
by: Ding Y, et al.
Published: (2022-05-01)

National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018
by: Allan Klitgaard, et al.
Published: (2024-02-01)

Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials
by: Hong Chen, et al.
Published: (2021-06-01)

Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
by: Cheng SL
Published: (2018-09-01)